Lizabeth Clarke, MD
Otolaryngology · New Iberia, LANPI 1427046259
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $38,250 of the $39,900 with a category attached, or 95.9%. Lilly USA, LLC accounts for 96.6% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $38,869, more than ten times the $337 reported in 2019. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $395.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$39K
- Optinose US, Inc.$382
- AbbVie$152
- Sanofi$138
- Inspire Medical Systems, Inc.$121
- Hikma Pharmaceuticals USA$100
- plus $444 from 12 others
What the payments were for
- Speaking & faculty fees$38,25096%
- Travel & lodging$130%
- Food & beverage$1,6374%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 36 | $38,563 |
| Optinose US, Inc. | 23 | $382 |
| AbbVie(2 entities) | 2 | $152 |
| Sanofi | 6 | $138 |
| Inspire Medical Systems, Inc. | 3 | $121 |
| Hikma Pharmaceuticals USA | 6 | $100 |
| Regeneron Healthcare Solutions, Inc. | 4 | $76 |
| GSK | 3 | $66 |
| Acclarent, Inc | 3 | $57 |
| Alk-abello, Inc | 3 | $55 |
| Advanced Bionics, LLC | 2 | $33 |
| 3b Medical, Inc. | 1 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Jazz Pharmaceuticals Inc. | 2 | $25 |
| Almirall LLC | 2 | $22 |
| Itamar Medical Inc | 1 | $21 |
| Aerin Medical Inc. | 1 | $18 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,900 in reported general payments places this provider in the 95th percentile of 218 otolaryngology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 12 | $1,475 |
| Fluticasone Propionate | 104 | $1,272 |
| Azelastine Hcl | 45 | $983 |
| Ipratropium Bromide | 22 | $862 |
| Ofloxacin | 14 | $434 |
| Fluocinolone Acetonide Oil | 11 | $398 |
| Mupirocin | 35 | $266 |
| Montelukast Sodium | 27 | $240 |
| Famotidine | 29 | $182 |
| Mometasone Furoate | 11 | $111 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 12 | $59 |
| Prednisone | 13 | $19 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New Iberia
- Charles MooreNew Iberia$6K
- Donald GonzalesNew Orleans$351K
- Kevin McLaughlinCovington$186K
- Adil FatakiaMarrero$148K
- Edward McCoulNew Orleans$92K
- Michael YimShreveport$77K
- Maura CosettiShreveport$64K
- Henry BarhamBaton Rouge$32K
- Cherie-Ann NathanShreveport$32K
- Jesse DuplechainLafayette$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.